Long-term safety and efficacy of high-concentration (20 μg/g) tacalcitol ointment in psoriasis vulgaris

European Journal of Dermatology

Volumn 12, Issue 5, 2002, Pages 463-468

  Miyachi, Yoshiki ^a   Ohkawara, Akira ^a   Ohkido, Muneo ^a   Harada, Shotaro ^a   Tamaki, Kunihiko ^a   Nakagawa, Hidemi ^a   Hori, Yoshiaki ^a   Nishiyama, Shigeo ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Intact PTH; Long term administration; Psoriasis vulgaris; Tacalcitol ointment

Indexed keywords

CALCIUM ION; PARATHYROID HORMONE; TACALCITOL;

ADOLESCENT; ADULT; AGED; ARTICLE; CALCIUM BLOOD LEVEL; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; ERYTHEMA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OINTMENT; PARATHYROID HORMONE BLOOD LEVEL; PRURITUS; PSORIASIS; PSORIASIS VULGARIS; SKIN IRRITATION; TREATMENT OUTCOME;

ADMINISTRATION, TOPICAL; ADOLESCENT; ADULT; AGED; CONFIDENCE INTERVALS; DERMATOLOGIC AGENTS; DIHYDROXYCHOLECALCIFEROLS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; OINTMENTS; PROBABILITY; PROSPECTIVE STUDIES; PSORIASIS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 0036750636     PISSN: 11671122     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Rea JN, Newhouse ML, Halil T. Skin disease in Lambeth. A community study of prevalence and use of medicai care. Br J Prev Soc Med 1976; 30: 107-14.
2. Brandrup F, Green A. The prevalence of psoriasis in Denmark. Acta Derm Venereol 1981; 61: 344-6.
3. 3. Med J Osaka Univ 1985; 35: 51-4.
4. 3 with high activity for inducing epidermal differentiation but decreased hypercalcemic activity. J Dematol 1990; 17: 135-42.
5. 3 (TV-02) (1). Xenobio Metabol and Dispos 1990; 5: 3-24.
6. 3 (TV-02) (3). Xenobio Metabol and Dispos 1990; 5: 39-52.
7. 3 In: Norman A W, Schaefer K, Herrath DV, eds. Vitamin D basic research and its clinical application. Berlin, New York: Walter de Gruyter & Co 1979: 1247-55.
8. High-concentration TV-02 ointment clinical study group. Late phase II study on the efficacy and usefulness of High-concentration TV-02 ointment for treating psoriasis vulgaris - A double-blind, right to left study comparing different concentrations of tacalcitol. Nishinihon J Dermatol 2002; 64: 88-104.
9. High-concentration TV-02 ointment clinical study group. Efficacy and safety of high-concentration TV-02 ointment in patients with psoriasis vulgaris - A double-blind, right to left comparative study (Phase III study). Nishinihon J Dermatol 2002; 64: 105-19.
10. High-concentration TV-02 ointment clinical study group. Safety and pharmacokinetics of high-concentration TV-02 ointment. Clinical pharamacological study - Nishinihon J Dermatol 2002; 64: 237-52.
11. Fredriksson T, Pettersson U. Severe psoriasis-oral therapy with a new retinoid. Dermatologica 1978; 157: 238-44.
12. Berth-Jones J, Bourke JF, Iqbal SJ, Hutchinson PE. Urine calcium excretion during treatment of psoriasis with topical calcipotriol. Br J Dermatol 1993; 129: 411-4.
13. Bourke JF, Berth-Jones J, Iqbal SJ, Hutchinson PE. High-dose topical calcipotriol in the treatment of extensive psoriasis vulgaris. Br J Dermatol 1993; 129: 74-6.
14. Dwyer C, Chapman RS. Calcipotriol and hypercalcaemia. Lancet 1991; 338: 764-5.
15. Cunliffe WJ, Berth-Jones J, Claudy A, Fairiss G, et al. Comparative study of calcipotriol (MC903) ointment and betamethasone 17-valerate ointment in patients with psoriasis vulgaris. J Am Acad Dermatol 1992; 26: 736-43.
16. Bourke JF, Mumford R, Whittaker P, Iqbal SJ, Le Van LW, Trevellyan A, Hutchinson PE, The effects of topical Calcipotriol on systemic calcium homeostasis in patients with chronic plaque psoriasis. J Am Acad Dermatol 1997; 37: 929-34.
17. Kerkhof PCM, Werfel T, Haustein UF, Luger T, Czarnetzki BM, Niemann R, Planitz-Stenzel V. Tacalcitol ointment in the treatment of psoriasis vulgaris: a multicentre, placebo-controlled, double-blind study on efficacy and safety. Br J Dermatol 1996; 135: 758-65.
18. Yoshikawa K, Nomura M, Higashiyama M, Muya M, et al. Clinical pharmacological study on MC903 ointment - Pharmacokinetic investigation in patients with psoriasis vulgaris. J Clin Therap Med 1995; 11: 2379-89 (in Japanese).
19. MC903 Ointment study group. Long-term treatment with MC903 (Calcipotriol) ointment in patients with psoriasis vulgaris - An open clinical trial. J Clin Therap Med 1995; 11: 2589-607.
20. Nishimura M, Hori Y, Nishiyama S, Nakamizo Y. Topical 1α,24(R)-dihydroxyvitamin D3 for the treatment of psoriasis. Review of the literature. Eur J Dermatol 1993; 3: 255-61.